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Abstract 
Aims 
To determine the blood transfusion rates following shoulder arthroplasty and to 
establish risk factors associated with increased risk of transfusion. 
Materials and Methods 
All shoulder arthroplasty cases performed between January 2012 – March 2017 in a 
tertiary upper limb unit were identified. Patients who received peri-operative 
tranexamic acid were excluded. Retrospective review of case notes was completed to 
identify transfusion rate and risk factors. Univariate and multi-variate analysis was 
performed to analyse the association between risk factors and transfusion rate. 
Results 
537 shoulder arthroplasties performed in 474 patients were included. Peri- or post-
operative transfusion was required in 21 cases (3.9%). Univariate analysis suggested 
significant association with age (p=0.005), female sex (0.015), pre-operative 
haemoglobin / haematocrit (p<0.001), peri-operative drop in haemoglobin (p<0.001) 
ASA grade (p<0.001) and transfusion rate. Only peri-operative drop in haemoglobin 
(p<0.001) and ASA grade (p=0.039) retained significance on multi-variable analysis. 
Conclusions 
The blood transfusion rate following shoulder arthoplasty was 3.9%. Greater peri-
operative drop in haemoglobin and higher ASA grade were associated with increased 
risk of transfusion on multivariate analysis. 
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Keywords 
Shoulder, arthroplasty, transfusion, outcome, complication 
Take Home Message 
• Low blood transfusion rate following shoulder arthroplasty compared to 
previous studies in literature 
• Increased peri-operative drop in haemoglobin and higher ASA grade associated 
with increased risk of transfusion 
Level of evidence – 2b Individual cohort study 
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Introduction 
Rates of shoulder arthroplasty are rapidly increasing in the UK with 5221 cases 
recorded on the National Joint Registry in 2015, a rise of greater than 100% since 2012. 
(1,2) As the volume of procedures increases, more attention is focused on improving 
peri-operative care to optimise patient outcomes and limit complications. Several large 
studies from the USA have examined the transfusion rate following shoulder 
arthroplasty, but at present no data has been published from a UK centre and data 
from the USA may not be generalisable to the population and healthcare setting in the 
UK. 
 
The reported rate of blood transfusion following shoulder arthroplasty varies from 
4.5%-43%, with more recent work reporting rates at the lower end of this range. (3-9) 
This compares favourably to transfusion rates of 16%-58% following hip and knee 
arthroplasty. (10-13) Transfusion in patients undergoing shoulder arthroplasty has 
been shown to be associated with a higher risk of medical complications, including 
myocardial infarction, pneumonia, thrombo-embolic event, as well has higher rates of 
local complication including peri-prosthetic infection. (1,4) 
 
Previous studies have attempted to identify risk factors for transfusion in shoulder 
arthroplasty patients. Padegimas et al reported that pre-operative haematocrit and 
surgery for post-traumatic arthritis were both significantly associated with an 
increased transfusion risk, with other studies suggesting that age, female sex, 
ischaemic heart disease and the use of cement were all implicated. (4,5,7,8) 
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Padegimas also reported that pre-operative haematocrit of 0.396 or lower has a 
sensitivity of 90% in predicting transfusion following shoulder arthoplasty. (4,9) 
 
The purpose of this study was to examine the transfusion rate following shoulder 
arthoplasty in a high volume UK centre, which does not routinely use tranexamic acid 
for these cases, and to identify risk factors for transfusion. 
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Materials and Methods 
A consecutive series of shoulder arthroplasties performed at the host institution, a 
tertiary referral upper limb unit, between January 2012-March 2017 was identified.  
Patients were included if they underwent any form of shoulder arthroplasty, including 
anatomic total shoulder replacement, reverse total shoulder replacement, 
hemiarthroplasty and revision procedures for all indications. Patients were excluded if 
they received tranexamic acid during the peri-operative period (n=16). 
 
A review of case notes, online patient records, operation note and relevant 
anaesthetic charts was made to collect patient demographic data, details of co-
morbidities, pre-operative / post-operative blood results and details regarding timing 
and quantity of any transfusion given. Local blood transfusion protocols state that a 
transfusion trigger of 70g/L should be used if patients are asymptomatic, or 80g/L if 
patients are symptomatic or have a history of ischaemic heart disease. 
 
Univariable analysis (unpaired T-test for continuous variables, Chi squared or Fisher’s 
Exact Test for categorical data based on size of expected values) was used to evaluate 
the significance of all measured variables. Multi-variable regression analysis was 
performed using GraphPad InStat and Prism (GraphPad Software Inc, La Jolla, CA, 
USA). Significance was determined when p < 0.05. No cases had missing data, 
therefore multiple regression analysis was performed on all cases. The dependent 
variable was whether transfusion was received or not, the independent variables were 
the age at intervention, procedure type, indication for intervention, gender, pre-
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operative haemoglobin, post-operative haemoglobin, change between pre and post-
operative haemoglobin, pre-operative haematocrit, post-operative haematocrit, ASA 
grade and laterality. The R2 values were inspected to determine if multicollinearity 
was a problem in the model, if the R2 value was >0.9 then the included values were 
rationalised. This led to the exclusion of the post-operative haemoglobin and post-
operative haematocrit (with the pre-operative values and the haemoglobin drop being 
retained). 
 
This study was performed under the jurisdiction of the HRA and their decision making 
tool indicates that ethical approval is not required for the current study or study 
design. 
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Results 
During the period January 2012 – March 2017, 553 arthroplasties were carried out in 
490 patients. Of these 16 patients were given peri-operative tranexamic acid and 
therefore excluded, leaving 537 arthroplasties in 474 patients eligible for analysis. 
There were 382 procedures carried out in female patients (71%) and 155 in males 
(29%), overall the mean age was 71.6 years (24-93).  21 of 537 shoulder arthroplasties 
required a peri-operative transfusion (4%). Demographic details for all patients 
included are provided in table 1. 
 
The most common procedure was a primary anatomic total shoulder replacement, 
representing 235 (44%) of the cases, followed by reverse total shoulder replacement 
(224 cases; 42%), hemiarthoplasty (30 cases; 6%) and there were 48 revision 
procedures (9%). Of the 537 procedures undertaken, 258 were for osteoarthritis 
(48%), 136 for rotator cuff arthropathy (25%), 46 for trauma or trauma sequlae (9%), 
33 for rheumatoid arthritis (6%) and 16 for avascular necrosis (3%).  
 
A total of 39 units of packed red cells were transfused in 21 patients at a mean of 3 
days post-op. One transfusion was given intra-operatively. Univariate analysis 
suggested an association between increasing age, pre-operative haemoglobin, pre-
operative haematocrit, the peri-operative drop in haemoglobin and ASA with the risk 
of receiving a transfusion. Pre-operative haematocrit was analysed both as a 
continuous variable, and as a categorical variable of either less or greater than 0.396 
based on the work by Padegimas et al. (4) Using pre-operative haematocrit of less than 
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0.396 as an independent predictor of transfusion would have identified 18/21 
transfusions, a sensitivity of 86%. Many of these variables were not found to be 
significant on multi-variable analysis. 
Table 1. Demographic data of 474 patients undergoing 537 procedures 
Variable All Procedures Transfusion 
No 
Transfusion P Value 
No. of cases 537 21 516   
Age 71.6 77.4 71.3 0.005 
Gender       0.015 
Male 155 3 152   
Female 382 18 364   
Pre-op Hb (g/L) 132 119 132 <0.001 
Mean Hb Drop 
(g/L) 23 38 22 <0.001 
Pre-op Hct 0.4 0.36 0.4 <0.001 
Pre-op Hct       <0.001 
<0.396 235 18 217   
>0.396 302 3 299   
Laterality       0.65 
Right 300 13 287   
Left 237 8 229   
Procedure       0.13 
Anatomic 235 6 229   
Reverse 224 14 210   
Hemiarthroplasty 30 0 30   
Revision 48 1 47   
Indication       0.14 
OA 258 4 254   
Cuff arthropathy 136 8 128   
AVN 16 2 15   
Acute trauma 6 0 6   
Post trauma 40 4 36   
RA 33 2 31   
Revision 48 1 46   
ASA       P<0.001 
1 52 0 52   
2 259 4 255   
3 217 13 204   
4 9 4 5   
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The multiple regression model for whether patients required transfusion or not 
showed a significant relationship (p<0.0001). The change between pre and post-
operative haemoglobin (p<0.0001) and the ASA grade (p<0.039) were significantly 
associated with the risk of transfusion. The other variables included (age at 
intervention, procedure type, indication for intervention, gender, pre-operative 
haemoglobin, pre-operative haematocrit, and laterality) did not (p=0.07-0.53). 
 
 
Table 2: Multiple regression models investigating the risk of transfusion 
Variable 
Coefficient 
95% Confidence 
Interval 
t ratio p value 
Age at operation 0.0007 -0.001 to 0.002 0.767 0.444 
Procedure type -0.0194 -0.043 to 0.004 1.618 0.106 
Indication for surgery 0.0038 -0.007 to 0.015 0.699 0.485 
Gender -0.0240 -0.061 to 0.013 1.256 0.210 
Pre-operative 
haemoglobin 
-0.0012 -0.004 to 0.002 0.753 0.452 
Change from pre to 
post-operative 
haemoglobin 
0.0063 0.005 to 0.008 8.166 <0.0001 
Pre-operative 
haematocrit 
-1.050 -2.185 to 0.084 1.814 0.070 
ASA grade 0.0266 0.001 to 0.052 2.075 0.039 
Laterality 0.010 -0.021 to 0.040 0.622 0.534 
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Discussion 
This study reports an overall transfusion rate of 3.9% following 537 shoulder 
arthoplasty procedures. The demographic characteristics of the population studied are 
comparable both to previous published work and to the data reported by the National 
Joint Registry of England, Wales and Northern Ireland (NJR). Univariate analysis 
suggested that increasing age, female sex, lower pre-operative hameoglobin and 
haematocrit, higher peri-operative drop in hameoglobin and higher ASA grade were all 
significantly associated with transfusion risk. On multivariate analysis only the peri-
operative drop in haemoglobin and the ASA grade remained significant predictors of 
peri-operative transfusion. 
 
Historical studies have shown very high rates of transfusion following shoulder 
arthroplasty, with Gruson et al. reporting a transfusion rate of 43%. (9) More recent 
work has shown greatly decreased rates of transfusion with Padegimas et al., Kandil et 
al. and Hardy et al. reporting rates of 4.5%, 6.1% and 7.4% respectively. (4,5,9) The 
transfusion rate of 3.9% reported here is lower than previously recorded rates, but in 
keeping with the more recent publications. The low transfusion rate reported could be 
influenced by several factors. Firstly institutional protocols determining when patients 
require a transfusion may vary, our institution advises transfusion when the 
haemoglobin is less than 70g/L, or when the value is less than 80g/L and the patient is 
symptomatic or has a history of ischaemic heart disease. Patients who are found to be 
anaemic at pre-operative assessment are referred for further investigation, with 
surgery often delayed in these cases whilst pre-operative optimization is carried out. 
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This occasionally leads to pre-operative iron supplementation either orally or via intra-
venous infusion. 
 
In hip and knee arthroplasty, the use of peri-operative tranexamic acid is 
commonplace, and in recent years consideration has been given to its use in shoulder 
arthroplasty. Multiple randomised controlled trials have found that tranexamic acid 
use during shoulder arthroplasty decreases intra-operative blood loss, drop in 
haemoglobin and transfusion requirement. (3,6) A meta-analysis on the subject 
concluded that tranexamic acid use was associated with a lower transfusion 
requirement and no increase in thrombotic events. (10) With transfusion rates as low 
as 3.9% surgeons could question the case for blanket use of tranexamic acid. However 
given the increased complication risk associated with transfusion (1), it’s confirmed 
role in reducing peri-operative blood loss and favourable side effect profile (10) there 
is clearly a role for peri-operative tranexamic acid in shoulder arthroplasty. 
 
A key step in the prevention of transfusion is identifying the patients most at risk. 
Padegimas et al. reported that pre-operative haematocrit and surgery for post-
traumatic arthritis were both independent risk factors for transfusion, going on to 
state that a pre-operative haematocrit threshold of <0.396 had a 90% sensitivity for 
identifying patients who would require a transfusion. (4) In this analysis pre-operative 
haematocrit appeared to show a significant association with transfusion in univariate 
analysis, but no significant association was demonstrated between transfusion and 
either pre-operative haematocrit or indication for surgery on multi-variable analysis. 
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Using a pre-operative Haematocrit threshold of <0.396 identified 18 out 21 (86%) of 
transfusions in this study, patients with a pre-operative haematocrit of >0.396 had a 
3/302 (1%) risk of transfusion. 
 
Analysis of risk factors for transfusion by Kandil et al., Ahmadi et al. and Hardey et al. 
identified increasing age, female sex, low pre-operative haemoglobin, increased 
surgical blood loss and patient co-morbidities to be significantly associated with 
transfusion risk. (5,7,8) Whilst univariate analysis suggested a positive association with 
age, gender and pre-operative haemoglobin, no association was demonstrated on 
multiple variable analysis. The only positive predictors of transfusion risk on multi-
variable analysis were the peri-operative drop in haemoglobin, and the patients ASA 
grade. 
 
The strengths of this paper are that it is a large comprehensive, consecutive series of 
shoulder arthoplasty cases from a single UK centre with a low rate of case exclusion. It 
must be stated that the numbers are small when compared to national population 
level studies from the USA. It is also a strength that this is the only work of this nature 
to have been done on a UK shoulder arthoplasty population. The limitations are that 
this was a retrospective study based on case note review, and the number of cases 
may have been too small to detect significant associations on multi-variate analysis. 
These cases were performed in a high volume UK centre so results may not be 
generalisable to all UK centres performing shoulder arthroplasty. The study design 
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used here is able to demonstrate an association between the considered variables and 
the risk of receiving a transfusion but is not able to definitively prove causation. 
 
Conclusions 
This study reports a low transfusion rate following shoulder arthroplasty of 3.9% in a 
UK population. Peri-operative drop in haemoglobin and a patient’s ASA grade were 
both independent predictors of transfusion. This study did not confirm previous 
findings that age, gender, pre-operative haemoglobin, pre-operative haematocrit, 
procedure and indication for shoulder arthroplasty are predictors of transfusion. 
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